Mr. Brenton L. Saunders is a Chairman at Scifluor Life Sciences LLC, a Chairman, President & Chief Executive Officer at Vesper Healthcare Acquisition Corp., an Independent Director at BridgeBio Pharma, Inc., an Independent Director at Cisco Systems, Inc., an Executive Chairman at The Beauty Health Co., an Independent Director at Trepont Acquisition Corp. I, a Member at Advanced Medical Technology Association, a Member at The Business Council and a Member at The Business Roundtable. He is on the Board of Directors at BridgeBio Pharma, Inc., Cisco Systems, Inc., Allergan Foundation, BridgeBio Pharma LLC, Trepont Acquisition Corp. I, Pharmaceutical Research & Manufacturers of America and University of Pittsburgh. Mr. Saunders was previously employed as a Chairman, President & Chief Executive Officer by Allergan Ltd. (Ireland), a President, Chief Executive Officer & Director by Forest Laboratories, Inc., a Chief Executive Officer & Director by Bausch + Lomb, Inc., a Chief Executive Officer & Director by Bausch & Lomb Holdings, Inc., a President-Global Consumer Health Care by Schering-Plough Corp., a Partner by PricewaterhouseCoopers LLP, a Chief Risk Officer by Coventry Health Care, Inc., a Senior VP-Compliance, Legal & Regulatory by Home Care America, Inc., a Co-Founder by Health Care Compliance Association, a Chief Compliance Officer by Thomas Jefferson University Hospital, a Chairman by American Heart Association, Inc., and a Trustee by RWJ Barnabas Health, Inc. He also served on the board at electroCore, Inc. and Overlook Hospital Foundation. He received his undergraduate degree from the University of Pittsburgh, a graduate degree from Temple University Beasley School of Law and an MBA from Fox School of Business.